Frager Factor

Friday, August 24, 2018

The Domain Gravy Train Has Passed. Time For A Better Idea.

Today: Pot, Cannabis, CGC, Canopy Growth, Millionaire, Investing, Medical Marijuana

How's That Million Of Yours Coming?
I Invested $37K Wednesday and 2 Days It's Worth $46K

A couple of days ago I reminded you about Canopy Growth Corporation. 

There is still time to get in one this now and turn a $1000 into a million if you have the patience to take a 5-10 year nap. 

The market is a no-brainer. We're not just talking stoners here, we're talking cures for diseases for which there was no hope before. Consider that one big pharma brand generates $70 billion year from a single pill.

We first recommended this here when it was $6 a share just about a year ago. Then we covered it again last December at $19 when Corona opted in

If you bought it 2 days ago when I recommended it at $40- it actually slipped to $37 and I bought 1000 shares more. So I invested $37K and two days later its at $46 and worth $46K.  And in the next 5-10 years it will be like Google and Amazon approaching $2,000 a share. You can't do this any more with domains. And there's only a few stocks in a lifetime that ever afford an opportunity like this at all.

There may never be another chance in your lifetime to REALLY accumulate the wealth that domains failed to deliver.

So get cracking!

America Is Giving Away the $30 Billion Medical Marijuana Industry
Why? Because the feds are bogarting the weed, while Israel and Canada are grabbing market share.

Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake


Legal Marijuana Market Worth $146.4 Billion by 2025 | CAGR: 34.6%

April 2018 | Report Format: Electronic (PDF) 
The global legal marijuana market is expected to reach USD 146.4 billion by end of 2025, according to a new report by Grand View Research, Inc. Growing adoption of marijuana in several medical applications such as cancer, mental disorders, chronic pain and others is expected to propel revenue growth in near future.

Legal marijuana has started gaining traction worldwide due to very high demand among consumers and increasing legalization of recreational or medical marijuana in various countries. Additionally, high public and private investment for research and the development of safer forms of ingesting marijuana such as tinctures, oils, vapes and other edibles are expected to positively reinforce market growth. The number of conditions treated using medical marijuana is growing rapidly, as new patients are added to the market, the demand for medical marijuana is expected to increase multiple folds over the forecast period. Countries like Canada and the U.S. are moving towards legalization of marijuana for recreational purposes, this in turn is expected to create a shift form medical to recreational marijuana. Lengthy purchase and approval process for medical marijuana prescription and ease of availability of recreational marijuana is expected to trigger this this change.

Increasing number of companies operating in the marijuana market is expected to bolster the quantity and variety of products reaching the end users. Products like marijuana oil have started gaining traction over the past few years owing to increased effectiveness and safety as compared to smoking it. Also, the growing research in cannabis industry has led to introduction of new marijuana strains. These advances in new product development is expected to enhance product adoption among consumers. Legal marijuana market is witnessing strong technological and information exchange. Countries like Canada, the U.S., Germany and Australia are expected to emerge as leading markets in terms of sale, whereas, countries like Israel are focusing on research and technology development and are leveraging on knowledge transfer.

 To request a sample copy or view summary of this report, click the link below:
urther Key Findings From the Report Suggest:
  • The U.S. legal marijuana market size was estimated at USD 7.06 billion in 2016 and is expected to grow at a CAGR of 24.9% from 2017 to 2025
  • Medical marijuana emerged as the largest marijuana type segment in 2016 and is estimated to be valued at USD 100.03 billion by 2025
  • By product type, marijuana buds segment was estimated to be dominant in 2016 with revenue share of 62.9% and is estimated to be valued at USD 82.9 billion by end of 2025
  • Some players operating in legal marijuana market are Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, The Cronos Group, Organigram Holdings, Inc, ABcann Medicinals, Inc., and Tikun Olam 
Grand View Research has segmented the global legal marijuana market on the basis of product type, application and region:
Marijuana Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Medical Marijuana
  • Recreational Marijuana
Product Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Buds
  • Oil
  • Tinctures
Medical Application Outlook (Revenue, USD Million, 2014 - 2025)
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • Italy
  • Asia Pacific
    • Australia
  • Latin America
    • Uruguay
  • Middle East & Africa
    • Israel

About The Author: Owen Frager is an Internet marketing expert ready to help take your company to the next level.

Contact Owen: Twitter | Google+ | Facebook | LinkedIn | Email